Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases

Standard chemotherapy for women with advanced or recurrent cervical cancer involves a combination of paclitaxel, platinum, and bevacizumab. However, for patients who experience anaphylaxis in response to paclitaxel or platinum, have permanent peripheral neuropathy, or develop early recurrence or pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Isono-Nakata, Rose, Tsubamoto, Hiroshi, Ueda, Tomoko, Inoue, Kayo, Shibahara, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909023/
https://www.ncbi.nlm.nih.gov/pubmed/29682600
http://dx.doi.org/10.1016/j.gore.2018.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909023/
https://www.ncbi.nlm.nih.gov/pubmed/29682600
http://dx.doi.org/10.1016/j.gore.2018.04.001

Ejemplares similares